US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust Dorsey Wright Dynamic Focus 5 ETF

42.28

-0.4250-1.00%

Volume:4K

Turnover:166.37K

Market Cap:109.92M

PE:- -

High:42.28

Open:42.04

Low:42.02

Close:42.70

52wk High:44.23

52wk Low:33.81

Shares:2.60M

Float Shares:2.60M

Volume Ratio:0.50

T/O Rate:0.15%

Dividend:0.55

Dividend Rate:1.30%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Treasury's Buyback Push Could Weaken Dollar, Deutsche Bank Warns

Press Release: Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Press Release: aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/FVC"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FVC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FVC\",,,,,undefined,":{"symbol":"FVC","market":"US","secType":"STK","nameCN":"First Trust Dorsey Wright Dynamic Focus 5 ETF","latestPrice":42.275,"timestamp":1787601600000,"preClose":42.7,"halted":0,"volume":3953,"delay":0,"changeRate":-0.009953161592505954,"floatShares":2600002,"shares":2600002,"eps":0,"marketStatus":"Pre-Mkt","change":-0.425,"latestTime":"08-25 09:12:39 EDT","open":42.0395,"high":42.275,"low":42.0201,"amount":166374,"amplitude":0.00597,"askPrice":50.23,"askSize":200,"bidPrice":34.92,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":42.275,"sharesOutstanding":2750002,"nav":42.69,"aum":110994085.38,"dividendRate":0.013001,"bidAskSpread":0.004204,"postHourTrading":{"tag":"盘后","latestPrice":42.23,"preClose":42.275,"latestTime":"16:10 EDT","volume":7,"amount":295.675,"timestamp":1787602205240,"change":-0.045,"changeRate":-0.001064,"amplitude":0},"volumeRatio":0.5007727539266142},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FVC\",,,,,undefined,":{"symbol":"FVC","floatShares":2600002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5007727539266142,"shares":2600002,"dividePrice":0.5496,"high":42.275,"amplitude":0.00597,"preClose":42.7,"low":42.0201,"week52Low":33.8116,"pbRate":"--","week52High":44.2299,"institutionHeld":0,"latestPrice":42.275,"eps":0,"divideRate":0.013001,"volume":3953,"delay":0,"ttmEps":0,"open":42.0395,"prevYearClose":36.368,"prevWeekClose":42.7,"prevMonthClose":40.1018,"prevQuarterClose":43.7984,"fiveDayClose":42.635,"twentyDayClose":40.1612,"sixtyDayClose":41.7413},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FVC\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"FVC","amount":0.0006,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2025-12-12","symbol":"FVC","amount":0.3232,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FVC","amount":0.2262,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-26","symbol":"FVC","amount":0.2677,"announcedDate":"2025-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-06-30"},{"date":"2025-03-27","symbol":"FVC","amount":0.1174,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-27","defaultRemindTime":1743082200000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-31","payableDate":"2025-03-27","currency":"USD","dateTimestamp":1743048000000,"payDate":"2025-03-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FVC\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-21","recordDate":"2016-09-23","paymentDate":"2016-09-30","value":0.0365,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0068,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.1017,"currency":"USD"},{"executeDate":"2017-06-22","recordDate":"2017-06-26","paymentDate":"2017-06-30","value":0.0169,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":"2017-09-22","paymentDate":"2017-09-29","value":0.0459,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FVC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FVC\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1193847087","title":"Treasury's Buyback Push Could Weaken Dollar, Deutsche Bank Warns","url":"https://stock-news.laohu8.com/highlight/detail?id=1193847087","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193847087?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:10","pubTimestamp":1787555450,"startTime":"0","endTime":"0","summary":"With U.S. debt surpassing the $40 trillion mark, global markets have shifted their focus from the sheer scale of the figure to how policymakers intend to manage the immense pressure it creates. The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVDV","AVRY","BGRO","BCPL","FLXI","SFTX","ACWX","FFDI","RFDI","HCRB","BRIE","JDVI","ROMO","FTRB","DIVA","SPCT","PIZ","USAF","MULT","LEXI","RAYD","BK4582","RFCI","BK4585","CGV","WLDR","BGH","WWJD","BK4550","PTIN","VGFPF","RODE","AHLT","TOUS","TINS","YLDE","GLBL","FIXP","JFLX","SSXU","CVY","SIO","BINT","IYLD","UIVM","XCOR","DWFI","QTAC","TSPX","ANEW","JHMD","CRXP","AAVM","UNIY","QBIV","ESGX","PZIV","JIII","TABD","PPIE","MVFG","RDFI","SCHC","FIRS","CDIG","RTRE","SMOM","JCPI","SLVX","TUG","WLTG","MNVT","FITZ","FTHB","CFIT","AVNV","VSLU","HIDV","BK4588","APIE","QWLD","INTF","INTL","FARX","JPIB","TBG","WTMF","RJMG","FAX","VEN","DWCR","PDN","NTZG","PIM","PYLD","IVAL","DFCF","FRWD","OGIG","LVIG","FDCE","EAGL","AMAX","FFUT","TOAO","PSDM","DXIV","FPAG","GAL","JFLI","FHIL","FPAA","RLY","TOTL","IQDY","EDGI","IDMO","GDMA","FID","GQGU","AQEC","EPIN","CGGE","XAGG","GIEQ","BINV","RGLO","BKIV","BKFI","PRAE","TAEQ","RINT","DYFI","IFV","PEXL","SNTH","TEK","CGDV","DTAN","DDX","ERNZ","PLGI","TCTL","WBND","NBGX","CGIC","WSGE","ESIM","TISC","ROIS","IMTM","TPUT","RDMX","ITDE","DDWM","IDEQ","EDGF","AVIV","MFSG","TMSF","FVC","ATFV","FLSP","RIGS","VYMI","TOAK","DFAX","NELS","IVLU","DBAW","DMX","FLDZ","URTH","MXI","GMOD","ISDX","ASGM","JPIE","ISEP","RW","TOK","TILC","CGUS","QDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972189","title":"Press Release: Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972189","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972189?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:00","pubTimestamp":1786536000,"startTime":"0","endTime":"0","summary":"double-blind, placebo-controlled global trial evaluating two doses of. AP01 dosed twice daily in patients with progressive pulmonary fibrosis. . This 52-week trial is designed to assess safety and efficacy of. AP01, with a primary endpoint of change in lung function measured by. forced vital capacity . The study overenrolled beyond its target. enrollment of 375, with a total of 398 patients randomized into three. treatment cohorts. Topline data are anticipated in the second half of. -- In September 2026, the Company plans to present two abstracts at the ERS. Congress in Barcelona, Spain. The first poster will highlight data. modeling effective AP01 distribution throughout the target tissue in both. healthy and idiopathic pulmonary fibrosis  lungs. The second poster. will describe the integration of patient perspectives into clinical trial. design. Detailed poster session information will be provided in advance","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","AVLN","IDNA","MEDX","BK4007","NVIB","HYLG","FVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658089139","title":"Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2658089139","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658089139?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:00","pubTimestamp":1786536000,"startTime":"0","endTime":"0","summary":"Completed enrollment of MIST global Phase 2b trial of AP01 with 398 patients; topline data expected in the second half of 2027 Two abstracts accepted for presentation at the European Respiratory Socie","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3343572/0/en/avalyn-reports-second-quarter-2026-financial-results-and-recent-business-highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","HYLG","NVIB","IDNA","FVC","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657625012","title":"Press Release: aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD","url":"https://stock-news.laohu8.com/highlight/detail?id=2657625012","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657625012?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:01","pubTimestamp":1786132860,"startTime":"0","endTime":"0","summary":"resources to support the efzofitimod program in ILD in anticipation of. comments from the FDA on a protocol submitted for a planned Phase 3 study. in pulmonary sarcoidosis and to complete the Phase 2 EFZO-CONNECT. -- Jill Broadfoot, aTyr's Chief Financial Officer , will step down as. of September 30, 2026, and transition to serve as a consultant t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4555","BK4588","FVC","TM","03160","BK4604","BK4139","ATYR","BK4099","CFO","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/FVC\",params:#limit:6,delay:false,,,undefined,":[]}}